Massive Intoxication with 70 Tablets of Apixaban: A Case Report
Abstract Apixaban is a direct oral anticoagulation agent that exerts its effect through the direct inhibition of factor Xa. We treated a case of massive intoxication with 70 tablets of apixaban and have presented the clinical course of the associated anti-Xa activities. A 49-year-old woman was admit...
Saved in:
Published in | Case reports in acute medicine Vol. 6; no. 1; pp. 13 - 18 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Basel, Switzerland
Karger Publishers
12.09.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Apixaban is a direct oral anticoagulation agent that exerts its effect through the direct inhibition of factor Xa. We treated a case of massive intoxication with 70 tablets of apixaban and have presented the clinical course of the associated anti-Xa activities. A 49-year-old woman was admitted to the emergency department approximately 1.5 h after impulsive self-intoxication with 175 mg of apixaban. She developed coagulopathy with prothrombin time-international normalized ratio (PT-INR) of 3.65, activated partial thromboplastin time of 56.5 s, and antithrombin activity (AT) of >150% (at 1.5 h post-ingestion). The patient’s initial and peak anti-Xa activity was 17.7 IU/mL, and its elimination displayed first-order kinetics with a half-life of 10.5 h. The patient’s anti-Xa activity was within the therapeutic dose range at 26 h post-ingestion, and she recovered without experiencing any bleeding complications. Her coagulopathy also returned to normal level at the same timing. This result suggests that PT-INR and AT can be used as substitute markers of overwhelmed anticoagulation following massive overdose of apixaban. A case of apixaban overdose with associated anti-Xa activities was presented. There was favorable resolution of anticoagulation without specific treatments. |
---|---|
AbstractList | Apixaban is a direct oral anticoagulation agent that exerts its effect through the direct inhibition of factor Xa. We treated a case of massive intoxication with 70 tablets of apixaban and have presented the clinical course of the associated anti-Xa activities. A 49-year-old woman was admitted to the emergency department approximately 1.5 h after impulsive self-intoxication with 175 mg of apixaban. She developed coagulopathy with prothrombin time-international normalized ratio (PT-INR) of 3.65, activated partial thromboplastin time of 56.5 s, and antithrombin activity (AT) of >150% (at 1.5 h post-ingestion). The patient’s initial and peak anti-Xa activity was 17.7 IU/mL, and its elimination displayed first-order kinetics with a half-life of 10.5 h. The patient’s anti-Xa activity was within the therapeutic dose range at 26 h post-ingestion, and she recovered without experiencing any bleeding complications. Her coagulopathy also returned to normal level at the same timing. This result suggests that PT-INR and AT can be used as substitute markers of overwhelmed anticoagulation following massive overdose of apixaban. A case of apixaban overdose with associated anti-Xa activities was presented. There was favorable resolution of anticoagulation without specific treatments. Abstract Apixaban is a direct oral anticoagulation agent that exerts its effect through the direct inhibition of factor Xa. We treated a case of massive intoxication with 70 tablets of apixaban and have presented the clinical course of the associated anti-Xa activities. A 49-year-old woman was admitted to the emergency department approximately 1.5 h after impulsive self-intoxication with 175 mg of apixaban. She developed coagulopathy with prothrombin time-international normalized ratio (PT-INR) of 3.65, activated partial thromboplastin time of 56.5 s, and antithrombin activity (AT) of >150% (at 1.5 h post-ingestion). The patient’s initial and peak anti-Xa activity was 17.7 IU/mL, and its elimination displayed first-order kinetics with a half-life of 10.5 h. The patient’s anti-Xa activity was within the therapeutic dose range at 26 h post-ingestion, and she recovered without experiencing any bleeding complications. Her coagulopathy also returned to normal level at the same timing. This result suggests that PT-INR and AT can be used as substitute markers of overwhelmed anticoagulation following massive overdose of apixaban. A case of apixaban overdose with associated anti-Xa activities was presented. There was favorable resolution of anticoagulation without specific treatments. |
Author | Saito, Satoko Kobayashi, Tadahiro Takada, Masayuki Nakane, Masaki Sakaguchi, Kento Tanaka, Ken Takahashi, Kazunori Kawamae, Kaneyuki |
Author_xml | – sequence: 1 givenname: Tadahiro surname: Kobayashi fullname: Kobayashi, Tadahiro email: *Tadahiro Kobayashi, ta-kobayashi@med.id.yamagata-u.ac.jp – sequence: 2 givenname: Satoko surname: Saito fullname: Saito, Satoko – sequence: 3 givenname: Masayuki surname: Takada fullname: Takada, Masayuki – sequence: 4 givenname: Kento surname: Sakaguchi fullname: Sakaguchi, Kento – sequence: 5 givenname: Kazunori surname: Takahashi fullname: Takahashi, Kazunori – sequence: 6 givenname: Ken surname: Tanaka fullname: Tanaka, Ken – sequence: 7 givenname: Kaneyuki surname: Kawamae fullname: Kawamae, Kaneyuki – sequence: 8 givenname: Masaki surname: Nakane fullname: Nakane, Masaki |
BookMark | eNpt0M9LwzAUwPEgCs65g3cPAU8eqvnVpfEipfhjMBHGPJfX_JidsylJ0fnfW-0YHjy98PjwhbwTdNj4xiJ0RskVpam6JoSknKeMHKARS4lIUpZlh3_ex2gS47pnTCpBOB2h2yeIsf6weNZ0fltr6Grf4M-6e8WS4CVUG9tF7B3O23oLFTQ3OMcFRIsXtvWhO0VHDjbRTnZzjF7u75bFYzJ_fpgV-TzRLKUk0SJVkgvJecY4NxysYU5IRZ3hWlYus2YqZWZUaoBqw3sMmRTUUC6Vq4CP0WzoGg_rsg31O4Sv0kNd_i58WJUQulpvbCktMEWnRvS_FI4o0BVzVnNLhMqkZH3rcmjp4GMM1u17lJQ_hyz3h-ztxWDfIKxs2MtikQ-ibI3r1fm_ahf5BleyeMc |
Cites_doi | 10.1111/jth.12720 10.1016/j.ajem.2016.11.035 10.1080/15563650.2016.1204453 10.1111/bcp.12106 10.1097/MBC.0000000000000706 10.1160/TH17-07-0474 10.1056/NEJMoa1814051 10.1111/ijlh.12640 10.1111/bcp.13790 10.1111/jth.13912 |
ContentType | Journal Article |
Copyright | 2023 The Author(s). Published by S. Karger AG, Basel |
Copyright_xml | – notice: 2023 The Author(s). Published by S. Karger AG, Basel |
DBID | M-- AAYXX CITATION DOA |
DOI | 10.1159/000533520 |
DatabaseName | Karger Open Access CrossRef Open Access: DOAJ - Directory of Open Access Journals |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: M-- name: Karger Open Access url: https://www.karger.com/OpenAccess sourceTypes: Enrichment Source Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2504-5288 |
EndPage | 18 |
ExternalDocumentID | oai_doaj_org_article_7ea2916d40274f09acb2fec3e0498772 10_1159_000533520 533520 |
GroupedDBID | 0R~ AAJPQ ABPAZ AELET AETAF AEYAO ALMA_UNASSIGNED_HOLDINGS EBS EMOBN GROUPED_DOAJ IAO IHR M-- M~E O9- OK1 RKO AAYXX CITATION ITC |
ID | FETCH-LOGICAL-c2510-c4597347338233d3aed2f4791fd3c7bf8ed6778d95da1cd3973a8741d1379fba3 |
IEDL.DBID | DOA |
ISSN | 2504-5288 |
IngestDate | Tue Oct 22 15:15:51 EDT 2024 Thu Sep 26 21:25:14 EDT 2024 Thu Aug 29 12:04:28 EDT 2024 Sat Aug 31 21:00:32 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Anti-Xa activity Intoxication Prothrombin time-international normalized ratio Antithrombin activity Apixaban |
Language | English |
License | This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2510-c4597347338233d3aed2f4791fd3c7bf8ed6778d95da1cd3973a8741d1379fba3 |
OpenAccessLink | https://doaj.org/article/7ea2916d40274f09acb2fec3e0498772 |
PageCount | 6 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_7ea2916d40274f09acb2fec3e0498772 crossref_primary_10_1159_000533520 karger_primary_533520 |
PublicationCentury | 2000 |
PublicationDate | 20230912 |
PublicationDateYYYYMMDD | 2023-09-12 |
PublicationDate_xml | – month: 09 year: 2023 text: 20230912 day: 12 |
PublicationDecade | 2020 |
PublicationPlace | Basel, Switzerland |
PublicationPlace_xml | – name: Basel, Switzerland |
PublicationTitle | Case reports in acute medicine |
PublicationTitleAlternate | Case Rep Acute Med |
PublicationYear | 2023 |
Publisher | Karger Publishers |
Publisher_xml | – name: Karger Publishers |
References | Dale BJ, Ginsberg JS, Johnston M, Hirsh J, Weitz JI, Eikelboom JW. Comparison of the effects of apixaban and rivaroxaban on Prothrombin and activated partial thromboplastin times using various reagents. J Thromb Haemost. 2014;12(11):1810–5. Franck B, Dulaurent S, El Balkhi S, Monchaud C, Picard N, Marquet P. Self-poisoning with 60 tablets of apixaban, a pharmacokinetics case report. Br J Clin Pharmacol. 2019;85(1):270–2. Guadarrama DS, DeMarinis SM, Sweeney JD. Coagulation assays in a case of apixaban overdose. Blood Coagul Fibrinolysis. 2018;29(2):231–5. Frost C, Nepal S, Wang J, Schuster A, Byon W, Boyd RA. Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects. Br J Clin Pharmacol. 2013;76(5):776–86. Leikin SM, Patel H, Welker KL, Leikin JB. The X factor: lack of bleeding after an acute apixaban overdose. AmJ Emerg Med. 2017355801.e5801.e6. Mast L, Verheul RJ, Reijnen R, van Rossen RCJM, Overdiek JWPM, Wilms EB. Apixaban auto-intoxication: toxicokinetics and coagulation tests. Thromb Haemost. 2017;117:2209–11. Douxfils J, Ageno W, Samama CM, Lessire S, Ten Cate H, Verhamme P. Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians. J Thromb Haemost. 2018;16(2):209–19. Van Blerk M, Bailleul E, Chatelain B, Demulder A, Devreese K, Douxfils J. Influence of apixaban on commonly used coagulation assays: results from the Belgian national external quality assessment scheme. Int J Lab Hematol. 2017;39(4):402–8. Barton J, Wong A, Graudins A. Anti-Xa activity in apixaban overdose: a case report. Clin Toxicol. 2016;54(9):871–3. Connolly SJ, Crowther M, Eikelboom JW, Gibson CM, Curnutte JT, Lawrence JH. Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. N Engl J Med. 2019;380(14):1326–35. ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref10 ref2 ref1 |
References_xml | – ident: ref9 doi: 10.1111/jth.12720 – ident: ref1 doi: 10.1016/j.ajem.2016.11.035 – ident: ref2 doi: 10.1080/15563650.2016.1204453 – ident: ref8 doi: 10.1111/bcp.12106 – ident: ref5 doi: 10.1097/MBC.0000000000000706 – ident: ref3 doi: 10.1160/TH17-07-0474 – ident: ref7 doi: 10.1056/NEJMoa1814051 – ident: ref10 doi: 10.1111/ijlh.12640 – ident: ref4 doi: 10.1111/bcp.13790 – ident: ref6 doi: 10.1111/jth.13912 |
SSID | ssj0002794031 |
Score | 2.2854123 |
Snippet | Abstract
Apixaban is a direct oral anticoagulation agent that exerts its effect through the direct inhibition of factor Xa. We treated a case of massive... Apixaban is a direct oral anticoagulation agent that exerts its effect through the direct inhibition of factor Xa. We treated a case of massive intoxication... |
SourceID | doaj crossref karger |
SourceType | Open Website Aggregation Database Enrichment Source Publisher |
StartPage | 13 |
SubjectTerms | anti-xa activity antithrombin activity apixaban Case Report intoxication prothrombin time-international normalized ratio |
SummonAdditionalLinks | – databaseName: Karger Open Access dbid: M-- link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3fS8MwEA6iIL6IPyZOpwTxNdgladP4InU4plAfZIO9lfwUEboxK-zP99J2xQm-pk0K12vv-y657xC69TKGz8ikRDkZE55oRmTkwgEba72OUu5r4fn8NZnM-Ms8nrf5jlAL8xnOP9fSqJ22AATcu6ZmNKZAzveoSHjw35yQLptCwa3APVvpoK0ZWwGn1uWHYNM85lckGR-hwxYC4qx5Z8dox5UnaD9vN7lP0UMOgBZ-Qvi5rBbrNqeGQ8IUiwhPQ61T9YUXHmfLj7XSqrzHGR5BNMINmu6h2fhpOpqQts8BMYAuImI4oHrGBQt7cswy5Sz1XMiht8wI7VNng8yblbFVQ2MBQTCVAhKwQyak14qdod1yUbpzhL2kSmjHPTUuULM0TTwwLpcwn9hI6T662RijWDZyFkVNA2JZdBbro8dgpu6GoEBdDyxW70Xr0IVwigK0tDzwWh9JZTT1zjAHlCMFyN5HvcbI3TKbxQd_xkdvWXOpWFp_8c-0S3QQGr2TunnDAO1Wq293BXCg0te1J_wA1vitRQ priority: 102 providerName: Karger AG |
Title | Massive Intoxication with 70 Tablets of Apixaban: A Case Report |
URI | https://karger.com/doi/10.1159/000533520 https://doaj.org/article/7ea2916d40274f09acb2fec3e0498772 |
Volume | 6 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSwMxEA7iQbyIj4rVKkG8hm432Ue8yFosVVgP0kJvS56gwrbUFfrznSTbsnjx4mUP2SUJM9nMN5nJNwjdWZ7Ab6RyIgxPCEslJTwyLsFGayujnFlPPF--ptM5e1kki06pL5cTFuiBg-CGmRExQBjNnP9kIy6UjK1R1AC0zQEa-t034h1n6sOH0ziD5dpSCYHJHoZbp4mr690xQJ6nH4zPp0u7Xncsy-QYHbWQEBdhKidoz9Sn6KBsg95n6KEEgAubEn6um-WmPWPD7gAVZxGeubtPzRdeWlys3jdCivoeF3gM1gkHdN1D88nTbDwlbd0DogBtREQxQPmUZdTF6KimwujYsoyPrKYqkzY32tG-aZ5oMVIaEAUVOSADPaIZt1LQc7RfL2tzgbDlscikYTZWxrlqeZ5a8MBMSm2qIyH76HYrjGoV6C0q7xYkvNpJrI8enZh2HzhGat8AeqpaPVV_6amPekHIu262nQ9-tY_fivCqWml7-R9jX6FDVyWe-MoPA7TfrL_NNWCJRt74ZQPPkpAf9lfDgg |
link.rule.ids | 315,783,787,867,2109,27649,27938,27939 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Massive+Intoxication+with+70+Tablets+of+Apixaban%3A+A+Case+Report&rft.jtitle=Case+reports+in+acute+medicine&rft.au=Tadahiro+Kobayashi&rft.au=Satoko+Saito&rft.au=Masayuki+Takada&rft.au=Kento+Sakaguchi&rft.date=2023-09-12&rft.pub=Karger+Publishers&rft.eissn=2504-5288&rft.volume=6&rft.issue=1&rft.spage=13&rft.epage=18&rft_id=info:doi/10.1159%2F000533520&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_7ea2916d40274f09acb2fec3e0498772 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2504-5288&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2504-5288&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2504-5288&client=summon |